The only milestones that matter are the US FDA and trial results. The rest are just noise, a distraction for the company and a way to burn cash needed to invest in a more focused strategy and making sure that you have the US prefessional societies on your side and max out the reimbursement fees. Both Sirtex and Therasphere hold value becasue of their US business the ROW stuff rides on the back of that and TBH could be zero and would probably make them more profitable. China is a pipe dream.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
95.0¢ |
Change
0.010(1.06%) |
Mkt cap ! $13.51M | |||
| Open | High | Low | Value | Volume |
| 95.0¢ | $1.02 | 94.0¢ | $110.7K | 114.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 15628 | 95.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.00 | 1909 | 2 |
View Market Depth
| Last trade - 16.10pm 17/06/2025 (20 minute delay) ? |
| OSL (ASX) Chart |